Ajayi Ikeoluwapo O, Soyannwo Tolulope, Akpa Onoja M
Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Department of Preventive Medicine and Primary Care, University of Ibadan, Ibadan, Nigeria.
Malar Res Treat. 2013;2013:176096. doi: 10.1155/2013/176096. Epub 2013 Dec 30.
Introduction. Distribution of Affordable Medicine Facility-malaria Artemisinin Combination Therapies (AMFm-ACTs) started in Nigeria in 2011, but its use at community level has not been documented. Methods. Four hundred seventy-eight caregivers whose under-five children had fever within two weeks prior to the survey were selected using cluster sampling technique. Information on sociodemographic characteristics, treatment seeking for malaria, and awareness and use of AMFm-ACTs was collected using an interviewer administered questionnaire. Result. More than half of the respondents (51.2%) bought AMFm-ACTs without prescription. Awareness of AMFm was low as only 9.1% has heard about the programme. Overall, 29.2% used AMFm-ACTs as their first line choice of antimalarial drug. On bivariate analysis age, group (25-34 years), public servants, respondents with tertiary education, respondents with high socioeconomic status, respondents with poor knowledge of symptoms of malaria, awareness of AMFm-ACTs, availability of AMFm-ACTs, and sources of drug were significantly associated with utilization of AMFm-ACTs (P < 0.05). Logistic regression demonstrated that only people who were aware of AMFM-ACTs predicted its use (AOR: 0.073; CI: 0.032-0.166; P < 0.001). Conclusion. Interventions which targeted at raising awareness of AMFm-ACTs among people at risk of malaria are advocated for implementation.
引言。2011年,尼日利亚开始分发平价药品设施-疟疾青蒿素联合疗法(AMFm-ACTs),但其在社区层面的使用情况尚无记录。方法。采用整群抽样技术,选取了478名在调查前两周内其五岁以下儿童发烧的看护人。通过访员管理的问卷收集了有关社会人口学特征、疟疾治疗寻求情况以及对AMFm-ACTs的知晓和使用情况的信息。结果。超过一半的受访者(51.2%)在没有处方的情况下购买了AMFm-ACTs。对AMFm的知晓率较低,只有9.1%的人听说过该项目。总体而言,29.2%的人将AMFm-ACTs作为抗疟药物的首选。在双变量分析中,年龄组(25 - 34岁)、公务员、受过高等教育的受访者、社会经济地位较高的受访者、对疟疾症状了解不足的受访者、对AMFm-ACTs的知晓情况、AMFm-ACTs的可获得性以及药品来源与AMFm-ACTs的使用显著相关(P < 0.05)。逻辑回归表明,只有知晓AMFM-ACTs的人预测会使用它(比值比:0.073;置信区间:0.032 - 0.166;P < 0.001)。结论。提倡实施旨在提高疟疾高危人群对AMFm-ACTs知晓率的干预措施。